PharmStars, the pharma-focused accelerator for digital health startups, announces that 13 startups have graduated from its Spring 2023 program focused on.
Happify Health chief strategy officer Chris Wasden discusses the company's partnership strategy, the business environment for digital therapeutics and how to encourage physician uptake.
The partnership with Zuellig Pharma includes Ensemble, Happify's therapeutic for treating major depressive disorder and generalized anxiety disorder, and a prescription digital therapeutic for chronic insomnia.